Oligonucleoside phosphorothioates.
Zon
G
G
Lynx Therapeutics, Inc., Foster City, CA.
D000107:Acetylation; D001331:Automation; D001482:Base Composition; D001671:Biochemistry / Q000379:methods; D002625:Chemistry, Organic / Q000379:methods; D002845:Chromatography / Q000379:methods; D004247:DNA / Q000138:chemical synthesis / Q000302:isolation & purification; D004963:Estrenes / Q000737:chemistry; D005456:Fluorescent Dyes; D009705:Nucleosides / Q000138:chemical synthesis* / Q000737:chemistry; D009841:Oligonucleotides / Q000138:chemical synthesis / Q000737:chemistry / Q000302:isolation & purification; D009943:Organophosphorus Compounds / Q000737:chemistry; D013237:Stereoisomerism; D013872:Thionucleosides / Q000138:chemical synthesis* / Q000737:chemistry; D013873:Thionucleotides / Q000138:chemical synthesis / Q000737:chemistry / Q000302:isolation & purification
D004963:Estrenes; D005456:Fluorescent Dyes; D009705:Nucleosides; D009841:Oligonucleotides; D009943:Organophosphorus Compounds; D013872:Thionucleosides; D013873:Thionucleotides; C051665:10-thiirane-4-estrene-3,17-dione; D004247:DNA